C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 1.405 AUD -6.64% Market Closed
Market Cap: 156.1m AUD
Have any thoughts about
Cyclopharm Ltd?
Write Note

Cyclopharm Ltd
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cyclopharm Ltd
PP&E Gross Peer Comparison

Comparables:
R
RSH
IPD
COH
OIL
EMV

Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
C
Cyclopharm Ltd
ASX:CYC
PP&E Gross
AU$10.4m
CAGR 3-Years
22%
CAGR 5-Years
9%
CAGR 10-Years
N/A
R
Respiri Ltd
ASX:RSH
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ImpediMed Ltd
ASX:IPD
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cochlear Ltd
ASX:COH
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Optiscan Imaging Ltd
ASX:OIL
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
EMvision Medical Devices Ltd
ASX:EMV
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Cyclopharm Ltd's PP&E Gross?
PP&E Gross
10.4m AUD

Based on the financial report for Jun 30, 2024, Cyclopharm Ltd's PP&E Gross amounts to 10.4m AUD.

What is Cyclopharm Ltd's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
9%

Over the last year, the PP&E Gross growth was 66%. The average annual PP&E Gross growth rates for Cyclopharm Ltd have been 22% over the past three years , 9% over the past five years .

Back to Top